TECHBio-Techne
$72.79+20% 1Y
$72.79
$43.2252 weeks$72.79
Latest close: a new 52-week highNov 6, 2026what changed →
Growth
Is TECH growing?
Bio-Techne's revenue has grown 2.4% a year over three years, and grown 4.5% a year over five, with earnings per share falling 10% a year.
+2.4%
Revenue growth, 3-year annual rate · Biotechnology median +21% · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +4.5%
Revenue growth, 5-year rate · +2.4% over three · the three-year rate is below the five-year rate
- Earnings per share, 3-year rate
- −10%
Earnings per share, 3-year rate · revenue +2.4% · earnings per share grew slower than revenue
- Years of annual history on file
- 18
Years of annual history on file · FY2009 to FY2026, as filed
Details›
- Revenue FY2022
- $1.11B
- Revenue FY2023
- $1.14B
- Revenue FY2024
- $1.16B
- Revenue FY2025
- $1.22B
- Revenue FY2026
- $1.22B
Annual income statements as filed with the SEC.
Where the revenue comes from
16 quarters, Dec 2022 to Sep 2026United States, quarter to Sep 2026from $149.0M in Dec 2022$152.7M
United States$152.7M
EMEA, excluding UK$73.9M
China$28.9M
APAC, excluding Greater China$22.5M
United Kingdom$13.7M
Rest of World$8.1M
On our screensStocks with more cash than debt
Biotechnology
The closest names by size in the same industry